Screening for chronic hepatitis B and C in migrants from Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam in the Arnhem region, the Netherlands

Epidemiology and Infection

Volumn 142, Issue 10, 2014, Pages 2140-2146

  Richter, C ^a   Beest, G Ter ^a   Gisolf, E H ^a   Van Bentum, P ^a   Waegemaekers, C ^b   Swanink, C ^a   Roovers, E ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b Municipal Health Service Arnhem   (Netherlands)

Author keywords

estimating; Hepatitis B; hepatitis C; prevalence of disease; screening programme

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS RNA;

ADULT; AFGHANISTAN; ARTICLE; BLOOD EXAMINATION; CHRONIC HEPATITIS; CHRONIC HEPATITIS B; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FIRST GENERATION MIGRANT; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; IMMIGRANT; IMMUNOSUPPRESSIVE TREATMENT; IRAN; IRAQ; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIGRANT; NETHERLANDS; PREVALENCE; QUESTIONNAIRE; REGISTER; RISK FACTOR; SEROLOGY; USSR; VIET NAM; VIETNAMESE;

ADOLESCENT; ADULT; AFGHANISTAN; EARLY MEDICAL INTERVENTION; EMIGRANTS AND IMMIGRANTS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; IRAN; IRAQ; LIVER CIRRHOSIS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PREVALENCE; USSR; VIETNAM; YOUNG ADULT;

EID: 84906319910     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813003415     Document Type: Article

References (23)

1. Marschall T, et al. High impact of migration in the prevalence of chronic hepatitis B in the Netherlands. European Journal of Gastroenterology & Hepatology 2008; 20: 1214-1225.
2. Kretzschmar M. The prevalence of hepatitis C in the Netherlands, VWS-IGZ 2004/02. Project V/210041. Bilthoven: RIVM, 2004.
3. Koedijk FD, et al. Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions. Nederlands Tijdschrift voor Geneeskunde 2007; 151: 2389-2394.
4. Kok A, et al. Hepatitis C in the Netherlands: sparse data on the current prevalence and the necessity for epidemiological studies and innovative methods for detecting infected individuals. Nederlands Tijdschrift voor Geneeskunde 2007; 151: 2367-2371.
5. Fox AN, Jacobsen IM. Recent successes and noteworthy future prospects in the treatment of chronic hepatitis C. Clinical Infectious Diseases 2012; 55 (Suppl. 1): S16-24.
6. Jesudian AB, de Jong YP, Jacobson IM. Emerging therapeutic targets for hepatitis C infection. Clinical Gastroenterology and Hepatology 2013; 11; 612-619.
7. Asselah T, Marcellin P. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B. Clinics in Liver Disease 2013; 17: 445-450.
8. Richter C, et al. Hepatitis B prevalence in the Turkish population of Arnhem: implications for national screening policyi Epidemiology and Infection 2012; 140: 724-730.
9. Nguyen VT. Hepatitis B infection in Vietnam: current issues and future challenges. Asia Pacific Journal of Public Health 2012; 24: 361-373.
10. Khan S, Attoullah S. Share of Afghanistan populace in hepatitis B and hepatitis C infection's pool: is it worthwhile? Virology Journal 2011; 8: 216-223.
11. Merat S, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Archives of Iranian Medicine 2009; 12: 225-231.
12. Salehi M, et al. Seroepidemiology of HBV infection in South-East of Iran: a population based study. Iran Red Crescent Medical Journal 2012; 14: 283-288.
13. Chironna M, et al. Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection 2003; 31: 70-74.
14. Batash S, et al. High prevalence of hepatitis C virus infection among immigrants from the former Soviet Union in the New York metropolitan area: results of a community based screening program. American Journal of Gastroenterology 2008; 103: 922-927.
15. Wilson JMG, Jungner G. Principles and practice of screening for disease. Public Health Papers. Geneva: World Health Organization, 1968.
16. EASL, Clinical Practice Guidelines: management of chronic hepatitis B virus infection. Journal of Hepatology 2012; 57: 167-185.
17. Niessen W, et al. Is personal invitation by letter effective for screening for hepatitis B virus? Infectieziekten Bulletin 2013; 4: 107-111.
18. Veldhuijzen IK, et al. Identification and treatment of chronic hepatitis B in Chinese migrants: results of a project offering on-site testing in Rotterdam. Hepatology 2012; 57: 1171-1176.
19. Hahne SJ, et al. Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007. Epidemiology and Infection 2012; 140: 1469-1480.
20. Urbanus AT, et al. Hepatitis C in the general population of various ethnic origins living in the Netherlands: Should non-Western migrants be screened? Hepatology 2011; 55: 1207-1214.
21. Uddin G, et al. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. Journal of Viral Hepatitis 2010; 17: 327-335.
22. Veldhuijzen IK, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is costeffective. Gastroenterology 2010; 138: 522-530.
23. Helsper CW, et al. Cost-effectiveness of targeted screening for hepatitis C in the Netherlands. Epidemiology and Infection 2012; 140: 58-69.